Your support gives clinicians resources to diagnose PANS/PANDAS and promptly begin treatment. Join us in helping those suffering now while working to fund research that will lead to a cure. Thank you!
PANS/PANDAS CLINICIAN RESOURCES
TREATING PANS/PANDAS
Access information on treating PANS and PANDAS with antimicrobials, immunomodulatory therapy, and psychotherapeutic and behavioral therapy.
SEEING YOUR FIRST PATIENT
This publication helps clinicians new to PANS/PANDAS by providing an overview, symptoms and diagnostic criteria, workup recommendations, and expectations.
FLOWCHARTS
Follow the process for determining the appropriate diagnosis and symptom severity based treatment protocols for mild, moderate, and severe/extreme cases.
WATCH THE FREE CME WEBINAR:
The Role of Adaptive Immunity and Genetic Risk Factors in Vascular and Neuronal Dysfunction in Post-Infectious Autoimmune Encephalitis
Presented by Dritan Agalliu, Ph.D.
OUR MISSION
The PPN mission is to maintain the industry standard PPN Guidelines for Diagnostics and Therapeutics, foster continuous education and communication within the multi-disciplinary medical community and to sponsor research for developing diagnostic tests, treatment protocols and a cure for PANDAS/PANS within this generation.
BECOME A MEMBER
► Receive email alerts on new research, guidelines, and treatment protocols
► Option to be recognized as a practitioner who works with PANS/PANDAS patients
► Become eligible to apply for a research grant
► Receive occasional members only benefits
ADVISORY COMMITTEES
Public Health Advisory Committees for PANDAS and PANS are done through a collaboration of health care and community-based partnerships. The list of committees are organized by state.
Research: Nature and Science of Sleep
Artificial Neural Networks Analysis of polysomnographic and clinical features in PANS: from sleep alteration to “Brain Fog”
“Polysomnography was abnormal in 73.9% of our patients which is consistent with the finding of PANS consortium reporting sleep alterations in about 80% of patients with PANS both at the onset of symptoms and after the acute phase.”
Research: Journal of Child and Adolescent Psychopharmacology
Evaluation of Intravenous Immunoglobulin in PANS
“In this population of PANS subjects, all psychometric endpoints studied exhibited statistically significant decreases following six infusions of IVIG…The durability of response is also noteworthy.”
PANS/PANDAS RESEARCH AND LITERATURE
CHANGE THE COURSE OF MENTAL ILLNESS
PPN is dedicated to impacting the research and education of PANS/PANDAS. Your donation to PPN will give physicians and medical professionals the resources they need to diagnose PANS/PANDAS in the early stages of the illness and promptly begin treatment. We are determined to help those suffering now while simultaneously working to fund research that will lead to a cure. Your support makes this possible. Thank you!